In this context, high CRP concentrations have been associated with adverse clinical consequences in various conditions, such as T2DM (Erkus et al. 1992), diabetic nephropathy (Aktas 2024; Bilgin et al. 2021), autoimmune thyroiditis (Demirkol and Aktas 2022), chronic hepatitis (Demirkol et al. 1992), and even COVID‐19 infection (Demirkol et al. 2022). This evidence concerns the gene CRP and type 2 diabetes mellitus.